SCHEMBL20510055

SCHEMBL20510055

COC(=O)c1ccc(F)c2c1OCC2=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.36
GAA P10253 3/20 0.36
GLA P06280 2/20 0.36
ABL1 P00519 1/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
PDK2 Q15119 1/20 0.35
PDK4 Q16654 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
MAPT P10636 2/20 0.35
MITF O75030 1/20 0.35
PKM P14618 1/20 0.34
ALDH1A1 P00352 6/20 0.34
PARP1 P09874 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20509570 0.81 PARP1 (0.37) PARP1NPC1SMN1; SMN2TSHRCASP1
SCHEMBL31358127 0.75 PSMB5 (0.37) PARP1
SCHEMBL5914650 0.74 MAPT (0.42) KDM4EGAAGLAABL1CA12
SCHEMBL13315471 0.73 KDM4E (0.42) KDM4EGAAGLAABL1CA12
SCHEMBL20510131 0.71 FADS1 (0.51) KDM4EMAPTALDH1A1NPC1RAB9A
SCHEMBL25550073 0.71 NPC1 (0.44) KDM4EGAAGLAABL1CA12
SCHEMBL6852355 0.70 TARBP2 (0.46) KDM4EGAAGLAABL1CA12
SCHEMBL6848305 0.70 KDM4E (0.56) KDM4EGAAGLAABL1CA12
SCHEMBL5759485 0.70 ABL1 (0.35) KDM4EGAAGLAABL1CA12
SCHEMBL5914658 0.69 HTR1A (0.34) KDM4EGAAGLAABL1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3601216-B1 SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDES AND ANALOGS THEREOF, AND METHODS USING SAME FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION ARBUTUS BIOPHARMA CORP (CA) 2023-10-25 EP disclosed
EP-3601216-B1 SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDES AND ANALOGS THEREOF, AND METHODS USING SAME FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION ARBUTUS BIOPHARMA CORP (CA) 2023-10-25 EP disclosed
EP-3601216-A1 SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDES AND ANALOGS THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2020-02-05 EP disclosed
WO-2018172852-A1 SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDES AND ANALOGS THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2018-09-27 WO disclosed